SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.18-5.1%Dec 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (7318)9/25/1998 2:03:00 PM
From: Robert K.  Read Replies (1) of 17367
 
Story again> about a 30 to 40 second spot>>>>>>>>>>>>>>>>>>>>
Something like>>>>
There may be a new class of drugs to fight resistant infections, or superbugs. The drug(s) act in a unique way to kill bacteria and may never be able to develop resistance. At the american society of
microbiologist meeting (thats Icaac) researchers are now completing final tests on humans before they seek fda approval.
end
Thats pretty much what is coming over the air. Good luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News